C:\Inetpub\websites\doctationsWebsite_production_2010.12.20\company\exec_board.asp
Dr. Cornacchia is the founder of DocPatientNetwork, Inc. as well as a practicing neurosurgeon and department chair. Dr. Cornacchia’s passion has always combined medicine and technology, both for the benefit of the healthcare industry, its physicians and its patients.
As a H.S. student he worked with Dr. Jacques Padawer in the Dept. of Anatomy at Albert Einstein College of Medicine, publishing an abstract on adjuvant therapy of CH3 mammary tumors with lucanthone and nitrogen mustard. While attending Columbia College (’82) he worked at Columbia P&S to publish an abstract on striated muscle fiber contraction kinetics with Professor Massataka Kawai. At Columbia, he also worked with Salvatore DiMauro and Sara Shanske and developed a technology for more efficiently dispensing centrifuged blood components and assisted in the research to ultimately demonstrate that certain diseases involving acid maltase deficiency can be diagnosed from a blood sample.
Dr. Cornacchia studied medicine at the NYU School of Medicine, graduating in 1987, with honors in cell biology for developing a comprehensive stereological analysis package in Fortran for analysis of electron micrograph data with Dr. Virginia Black. He then employed this technology in the study of Pompe’s disease and published work demonstrating abnormality in the peroxisome in patients afflicted with this disease. During his last year of medical school, he worked with Dr. Joseph Ransohoff and Dr. Rodolfo Llinas researching clinical applications of magneto-encephalography. At the NYU magneto-encephalography lab he analyzed ambient magnetic noise patterns and identified a prominent source of magnetic noise leading to a tool for noise cancellation and substantially improving data quality in the lab. He also participated in early research to localize the P200 auditory signal in Heschl’s gyrus in human subjects.
Dr. Cornacchia completed his internship and residency in neurosurgery at the University of California, San Diego in 1996 under John Alksne, M.D. While in residency training he developed and patented a device for automated injection of radionuclide during seizures to help facilitate imaging studies that can help localize the source of seizures in patients with epilepsy. He also developed a technique for visualizing brain cortical activity using voltage-dependent dies. He performed clinical research with Hoi Sang U demonstrating changes in cerebral blood volume before, during and after interventions for treatment of cerebral arteriovenous malformations. He also worked with Michael Swensen helping to define an electrodiagnostic technique for diagnosis of tarsal tunnel syndrome which was presented as an abstract.
After residency, Dr. Cornacchia founded New York Neurosurgery & Neuroscience Associates, PLLC and used his experience to help direct Mercy Medical Center to become one of the first hospitals in NY to install a Gamma Knife Center. Utilizing his medical and technology experience he also developed MiMS, a complete Electronic Health Record(EHR); Practice Management (PM); Revenue Cycle Management (RCM) System solution, which was used to run multiple medical practices from 1997 to 2001.
Dr. Cornacchia is a clinical assistant professor of Neurosurgery at Cornell-Weill Medical Center and at SUNY Downstate Medical Center. He is also chief of Neurosurgery at Brookdale University Hospital Medical Center in Brooklyn, New York where he has helped establish a "bloodless surgery" program. Lou is active in the American Association of Neurological Surgeons, the Congress of Neurosurgery, the American Medical Association and state/county medical organizations. He has published papers in several scientific and medical journals, including the Journal of Biophysics, The American Journal of Anatomy, Computers in Biology and Medicine, Muscle and Nerve, and the American Academy of Clinical Neurophysiology.
In 2001, Dr. Cornacchia undertook a massive project to begin development of a unique software platform for physicians and other providers, patients, hospitals, payers and government agencies designed to go beyond the limitations of siloed client-server based technologies which are still de reguer today. In 2005 he founded DocPatientNetwork, Inc (DPN) to engineer highly scalable “collaboration” technology designed to coerce the healthcare system towards reduced global healthcare costs and dramatically improved quality of care. His current research focus is in the application of multi-tenancy software architectures to solve stake-holder alignment, communications and interoperability issues in healthcare. This technology includes Internet-native web applications called 1) Doctations, which provides physicians with low-cost, comprehensive, extremely powerful EHR, PM, RCM and Internet Social Networking services online; 2) iMedicalHome which provides patients with a complete health care management platform online, including a state-of-the-art Patient Health Record; 3) iBillWell which provides patients, doctors, hospitals and other organizations with a complete Revenue Cycle Management and claims managements system online and 4) iTranscribe which provides very flexible dictation/transcription services online. His current research interests are the area of using the DPN multi-tenancy technology to help build a paradigm shift in healthcare by catalyzing stakeholder alignments in the healthcare industry to provide maximum possible quality of life and longevity for patients at the lowest possible cost.
Richard Toren founded CodeRyte, Inc., a software firm that offers physicians and hospitals an automated method of extracting billing codes from transcribed clinical records. The firm was started in 1998 and is rapidly growing.
He attended Penn State University for Pre-Med and graduated with a BS in marketing. He also attended the Loyola Graduate School of Business as part of the executive MBA program.
Rick has had extensive experience in hospital and medical device product development. He began his career in 1968 with McGaw Labs (subsidiary of American Hospital Supply) where he developed an IV additive anti-arrhythmic drug and a kit for administering hyper-alimentation nutrition. In 1971 he accepted a position with Survival Technology Inc., a pharmaceutical device development company. He served as Product Manager for emergency care products during which time he patented a neonatal electrode, developed an emergency care product line, established an international network of distributors, hired a direct sales force, built infrastructure, and increased revenue from zero to $12 million in 3 years. Later as Vice President of Sales and Marketing, Rick developed and marketed unique 24-hour ECG recording devices and help HCFA establish reimbursement guidelines for these new products.
As founder and CEO of Promedco, Inc., Rick managed and owned outpatient imaging centers in five states. He also managed physician practices in six specialties. Promedco was sold to Vivra (NYSE) in 1994 for $13 million. As President of the newly formed Vivra subsidiary, Vivra Heart Partners, he grew the medical management business from zero to a $55 million company with over 200 employees and acquired 65 physician cardiology practices.
Rick later founded and served as President of e-Medx. Inc., a software company that provided tools to payors and at-risk providers for medical management of populations. This company was sold to ActiveHealth Management where Rick continued as President of the CareSystems Division. This division provided care oversight (Case Management, Disease Management, and Utilization Review) to 2 million covered lives through six insurance company relationships. ActiveHealth Management was recently sold to Aetna for $400 million.
After e-Medx was sold, Rick took a position as President and COO of QED Solutions, Inc. where he directed the software firm’s growth in marketing data analysis software for pharmaceutical corporations to detect causal relationships with adverse events.
In addition to his current responsibilities at DocPatientNetwork, Rick also gives his time to the American Heart Association in the following roles:
Other Charitable Activities include:
Rick is married with four children and six grandchildren and occasionally has time to spend playing golf.
Arthur Goldberg is a director of SED International Holdings, an Amex-listed distributor of electronics, and chair of its Audit Committee. Since January 2008 he has held the position of chief financial officer of a publicly traded installer of photovoltaic solar energy systems for residential and commercial customers. Prior to that he served as interim CFO of Milestone Scientific, a publicly traded developer and distributor of selected medical and dental supplies. Prior to that position he was CAO and CFO of a college prep school and, from 1999 to 2005, Mr. Goldberg was a partner in the firm of Tatum CFO Partners LLP, serving as an interim CFO for both public and private companies. Mr. Goldberg earned his B.B.A. from the City College of New York, his M.B.A. from the University of Chicago and his J.D. and LL.M. from the New York University School of Law. Mr. Goldberg is also a Certified Public Accountant.
Joachim M. Do is the Chief Technology Officer at DocPatientNetwork, joining the company in 2006. He received his Bachelor´s degree in Computer Science from SUNY at Buffalo in 1997. He has had extensive experience developing cutting edge Internet technologies, including pioneering Web switch appliances with Arrowpoint Communications, a startup company later acquired by Cisco Systems. He has a track record of leading teams to successfully implement various complex n-tiered, eCommerce-enabled rich Internet applications.